Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney Disease
NCT ID: NCT01243515
Last Updated: 2013-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation of Physical Exam Versus Non-invasive Assessment Versus Invasive Assessment of Central Venous Pressure
NCT01574690
Comparison of Noninvasive Vs. Invasive Hemodynamic Measurements
NCT06689215
Non-Invasive CVP Method to Standard CVP Method
NCT03705299
Non-invasive Central Venous Pressure Estimation in Pediatric Patients
NCT06885073
Central Venous Pressure (CVP) Assessment by Ultrasound and Physical Examination
NCT01099241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is often difficult to identify the internal jugular vein to determine the JVP. The internal jugular vein is deep and adjacent to the carotid artery and pulsations derived from the artery may obscure the subtle venous pulsations. Manoeuvres to differentiate carotid pulsation and jugular pulsation are helpful in identifying the internal jugular vein, however determining the JVP based on the internal jugular vein examination is difficult.
Examination of the external jugular vein to determine JVP is an appealing alternative. The external jugular vein is easier to visualize and studies have demonstrated that this is a reliable method that correlates highly with catheter measured CVP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Kidney Disease
minimum 7 subjects (male and female)
Non-Invasive Central Venous Pressure monitor
An adhesive patch (connected to the Mespere NICVP monitor) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with CVP values obtained by physical examination (standard clinical practice)
Physical examination of jugular vein
Physicians assess CVP using the jugular vein of the subject
Healthy subjects
minimum 3 subjects (male and female)
Non-Invasive Central Venous Pressure monitor
An adhesive patch (connected to the Mespere NICVP monitor) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with CVP values obtained by physical examination (standard clinical practice)
Physical examination of jugular vein
Physicians assess CVP using the jugular vein of the subject
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Invasive Central Venous Pressure monitor
An adhesive patch (connected to the Mespere NICVP monitor) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with CVP values obtained by physical examination (standard clinical practice)
Physical examination of jugular vein
Physicians assess CVP using the jugular vein of the subject
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic Kidney Disease patients and healthy volunteers
* Participants should be able to provide written informed consent
* Subject is termed eligible as determined by Pre-Screening Phase (as defined in protocol)
Exclusion Criteria
* Unable to identify internal jugular vein (IJV)
* Unable to access right side of subject's neck
* Allergic to adhesive tape
* History of central vein stenosis
* Undergoing photodynamic therapy (PDT)
* Presence of an arteriovenous fistula
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Joseph's Healthcare Hamilton
OTHER
Mespere Lifesciences Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Azim S Gangji, MD
Role: PRINCIPAL_INVESTIGATOR
St. Joseph's Healthcare Hamilton
Melissa T Perri, MESc
Role: STUDY_DIRECTOR
Mespere Lifesciences Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Joseph's Hamilton Healthcare
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MLS STP-9000006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.